X0508 4 2025-03-19 false 0001082554 UNITED THERAPEUTICS Corp UTHR 0001231427 PATUSKY CHRISTOPHER C/O UNITED THERAPEUTICS CORPORATION 1000 SPRING STREET SILVER SPRING MD 20910 true false false false true Common Stock 2025-03-19 4 M false 5000.00 175.43 A 5900.00 D Common Stock 2025-03-19 4 S false 300.00 307.7332 D 5600.00 D Common Stock 2025-03-19 4 S false 1780.00 308.8208 D 3820.00 D Common Stock 2025-03-19 4 S false 328.00 309.7282 D 3492.00 D Common Stock 2025-03-19 4 S false 457.00 310.7989 D 3035.00 D Common Stock 2025-03-19 4 S false 736.00 312.2171 D 2299.00 D Common Stock 2025-03-19 4 S false 1299.00 313.14 D 1000.00 D Common Stock 2025-03-19 4 S false 100.00 313.77 D 900.00 D Common Stock 1100.00 I by Trust Stock Option 175.43 2025-03-19 4 M false 5000.00 0.00 D 2016-06-26 2025-06-26 Common Stock 5000.00 0.00 D This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on August 27, 2024. This transaction was executed in multiple trades at prices ranging from $307.32 to $308.125. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $308.44 to $309.31. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $309.48 to $310.37. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $310.48 to $310.89. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $311.68 to $312.66. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $312.735 to $313.72. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. /s/ John S. Hess, Jr. under Power of Attorney 2025-03-20